Piper Sandler Posts Record Q1 Revenue Led by DCM and Healthcare Gains
Piper Sandler posted record Q1 revenue thanks to a surge in debt capital markets advisory and spike in healthcare equity market share, even as large bank M&A closings slowed and sequential advisory fees were forecast lower due to choppy conditions. Its derivative desk saw increased hedging transactions amid rate volatility.
1. Record Revenue Drivers
Piper Sandler achieved record Q1 revenue as its Debt Capital Markets Advisory unit delivered a very strong quarter and the firm captured outsized market share in healthcare equity offerings and MedTech fees.
2. Bank M&A and Hedging Activity
Large bank M&A closings slowed below expectations in Q1, but activity in smaller transactions remained steady; meanwhile, the derivative desk saw increased hedging volumes as rate volatility prompted more client conversations and completed transactions.
3. Equity Capital Markets Performance
Healthcare and biotech equity capital markets drove the firm’s market share gains, though management cautioned that such outsized performance may not be sustainable as overall capital markets activity is expected to moderate in Q2.
4. Advisory and Non-M&A Strength
Advisory fees are forecast to decline sequentially due to choppy macro conditions, but non-M&A businesses—particularly debt capital markets and, to a lesser extent, private capital advisory and restructuring—provided solid contributions and highlighted strategic growth opportunities.